While PCSK9 inhibitors may plausibly interfere with pancreatic islets, there is currently no evidence of them increasing diabetes risk, unlike statins.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.